About me

Mervyn Singer is professor of intensive care medicine at University College London. His primary research interests are sepsis and multi-organ failure, infection, shock and haemodynamic monitoring. Funding for these activities primarily comes from the Wellcome Trust, Medical Research Council, European Union and National Institute for Health Research. He developed an oesophageal doppler haemodynamic monitor; multiple studies have shown its use to improve outcomes after major surgery and reduce length of stay. He co-developed the UCL Ventura CPAP device to support the breathing of COVID-19 patients in respiratory failure which has been widely distributed around the NHS and to many other countries. He has led on a number of important multi-centre trials in critical care, authored various papers and textbooks including the Oxford Handbook of Critical Care, now in its third edition, and is current chair of the International Sepsis Forum. He co-chaired the Sepsis-3 Definitions International Task Force that redefined sepsis in 2016; the resulting paper has had >three million views and is one of the most heavily cited in the scientific literature over the past five years. He was the first UK intensivist to be awarded senior investigator status by the National Institute for Health Research, and to be invited to give plenary lectures at the European and US Intensive Care Congresses.